Pathogen and host predictors of M. Tuberculosis transmission

Active Grant Awarded Last action

Award ID
R01AI194298
Recipient
Awarding agency
Obligated
$2,290,724

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date 24% complete
Place of performance
Nashville, TN 37203, USA

Award details come from USAspending.gov.

Description

Abstract
Common ways to measure M. Tuberculosis transmission are via acquisition of TH1-skewed T-cell immunity (e.g., interferon gamma release assays; igra) or new TB cases. However, these measurements may oversimplify and, in some cases, entirely miss M. Tuberculosis transmission. For example, a substantial minority of highly-exposed individuals have T-cell responses to M. Tuberculosis antigens that are not TH1- based. In addition, subclinical or asymptomatic TB is common, but often not captured clinically. Different strains of M. Tuberculosis may have evolved different solutions to optimize transmission, which may associate with distinct phenotypes. In addition, as M. Tuberculosis encounters hosts with different genetic backgrounds, immune status, age, and SEX, the manifestations of infection outcomes may vary, due to both bacterial and host factors. We hypothesize that M. Tuberculosis transmission outcomes are affected by both bacterial and human host (contact and index case) factors. We will test our hypothesis in the well-established report- brazil cohort study of TB cases and their close contacts. There were 1,188 TB cases and 1,930 contacts enrolled in phase 1 (2015-2021), and ~1,000 TB cases and ~2,000 contacts will be enrolled in phase 2 (2022- 2026). We will identify M. Tuberculosis bacterial genetic and phenotypic features associated with M. Tuberculosis transmission outcomes, including M. Tuberculosis infection, subclinical TB, and clinical TB disease through bacterial association studies and mechanistic evaluation. We will also define M. Tuberculosis transmission outcomes using multi-parameter profiling of human cellular immune responses in close contacts. Clinical and epidemiologic characteristics of the close contacts and their index TB cases will also be addressed, in prediction models of M. Tuberculosis transmission that also incorporate M. Tuberculosis genetic and host immune factors. Findings from this study could guide the development of targeted interventions, such as diagnostics for detecting highly transmissible M. Tuberculosis strains, and host-directed therapies aimed at modulating immune responses to reduce transmission risk. The results will also provide insights for optimizing public health strategies, including contact tracing and targeted preventive therapy, specifically tailored to high- transmission settings.

Transactions

Action Obligated Date
Amendment $244,334
Amendment $879,457
Amendment $326,817
Original award $840,116

Subawards

Subrecipient Amount Awarded
University Of North Carolina At Chapel Hill Pathogen and host predictors of M. tuberculosis transmission $222,594
Fiotec - Fundacao Para O Desenvolvimento Cientifico E Tecnologico Em Saude $244,334
University Of Washington 22-SEP-26 $29,765
University Of Washington Pathogen and host predictors of M. tuberculosis transmission $141,872
University Of North Carolina At Chapel Hill $110,212
President And Fellows Of Harvard College $34,325
University Of Washington $141,200
Fiotec - Fundacao Para O Desenvolvimento Cientifico E Tecnologico Em Saude $326,817

Quick answers

Who received award R01AI194298?

R01AI194298 was awarded to Vanderbilt University Medical Center by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 3, 2025.

How much is award R01AI194298 worth?

$2,290,724 has been obligated on R01AI194298.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award